|
'Exvading' Invasive Pediatric Brain Tumors
|
5R01CA153229-04
|
$231,106
|
$231,106
|
Bellamkonda, Ravi
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
(PQ6) Molecular Mechanisms of Dormancy in MYC-Driven Medulloblastoma
|
1R21CA180063-01
|
$254,475
|
$254,475
|
Pei, Yanxin
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
(PQC5) Detecting small clusters of tumor cells with a PTPmu probe
|
1R01CA179956-01
|
$645,638
|
$645,638
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
18F-Fluorocholine to distinguish necrosis from recurrence in brain metastases
|
1R21CA170289-01A1
|
$366,860
|
$366,860
|
Beal, Kathryn
|
SLOAN-KETTERING INST CAN RES
|
|
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN): A Phase II Clinica
|
2R44CA132257-03
|
$638,567
|
$638,567
|
MORGAN, Lee
|
DEKK-TEC, INC.
|
|
5-hydroxymethylcytosine in human cancer
|
5R01CA160965-02
|
$327,684
|
$163,842
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
A causal role for asymmetric cell division defects in glioma initiation
|
5R01CA164746-02
|
$301,353
|
$301,353
|
Petritsch, Claudia
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Novel Brachytherapy Agent for GBM
|
1R41CA165626-01A1
|
$299,937
|
$299,937
|
Calzone, Frank
|
APPLIED INTEGRIN SCIENCES, INC.
|
|
A novel photopatterning-based paradigm for the study of 3D tumor infiltration
|
1F32CA174361-01
|
$47,114
|
$47,114
|
Rape, Andrew
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A Predictive Prognostic Model for Glioblastoma Multiforme
|
5R01CA157553-02
|
$424,921
|
$424,921
|
BUI, ALEX
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Prospective Study of Social Competence in Pediatric Brain Tumor Survivors
|
1K07CA178100-01
|
$117,201
|
$117,201
|
Hocking, Matthew
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM
|
5R01CA136774-05
|
$292,312
|
$292,312
|
Pieper, Russell
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
A Wireless Laser Speckle and Fluorescence Imager for In vivo Brain Tumor Imaging
|
1R21CA175784-01
|
$208,713
|
$208,713
|
Pathak, Arvind
|
JOHNS HOPKINS UNIVERSITY
|
|
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
|
7R01CA151522-04
|
$222,309
|
$222,309
|
Hjelmeland, Anita
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,117,473
|
$55,874
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-37S2
|
$12,499
|
$250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-37
|
$7,216,850
|
$144,337
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Academic-Industrial Partnership to Develop Clinical Brain Cancer Imaging
|
1R01CA166171-01A1
|
$491,404
|
$491,404
|
ZHOU, JINYUAN
|
JOHNS HOPKINS UNIVERSITY
|
|
ADAM 17 and glioma-tumor progression and treatment
|
5R01CA129446-05
|
$274,338
|
$274,338
|
JIANG, FENG
|
HENRY FORD HEALTH SYSTEM
|
|
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
|
3R01CA125244-04S1
|
$61,181
|
$61,181
|
KRUSE, CAROL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
|
5R01CA125244-04
|
$1
|
$1
|
KRUSE, CAROL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Adult Brain Tumor Consortium (ABTC)
|
5U01CA137443-05
|
$1,698,364
|
$1,698,364
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors
|
5R01CA132899-05
|
$310,084
|
$310,084
|
Ris, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
Advanced MRI methods for detecting pseudo-progression of glioblastomas
|
1R21CA170284-01A1
|
$345,136
|
$345,136
|
Poptani, Harish
|
UNIVERSITY OF PENNSYLVANIA
|
|
Advancing Clinical Trails in Coastal North Carolina
|
1U10CA176852-01
|
$532,663
|
$5,327
|
MAGUIRE, PATRICK
|
NEW HANOVER REGIONAL MEDICAL CENTER
|
|
AEG-1: Novel Gene Involved in Malignant Glioma
|
5R01CA134721-05
|
$282,853
|
$282,853
|
FISHER, PAUL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Akt-EphA2 Crosstalk in Glioma Invasion
|
5R01CA152371-04
|
$306,229
|
$306,229
|
WANG, BINGCHENG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Alternative Mechanisms to Inactivate p53 During Oncogenesis
|
3R01CA156706-04S1
|
$42,493
|
$14,023
|
SHEN, ZHIYUAN
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Alternative Mechanisms to Inactivate p53 During Oncogenesis
|
7R01CA156706-04
|
$215,210
|
$71,019
|
SHEN, ZHIYUAN
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Alternative Mechanisms to Inactivate p53 During Oncogenesis
|
3R01CA156706-03S1
|
$17,202
|
$5,677
|
SHEN, ZHIYUAN
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Alternative Mechanisms to Inactivate p53 During Oncogenesis
|
5R01CA156706-03
|
$93,129
|
$30,733
|
SHEN, ZHIYUAN
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
American College of Radiology Imaging Network
|
3U10CA080098-14S2
|
$5,146,722
|
$205,869
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
An Integrated CT-based Image-Guided Neurosurgical System
|
5R44CA112966-04
|
$901,469
|
$901,469
|
Li, Senhu
|
XORAN TECHNOLOGIES, INC.
|
|
An Investigation of Radial Glia as the Source of Ependymoma Stem Cells
|
5R01CA129541-07
|
$303,174
|
$151,587
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Analysis of active and inactive EGFR conformations
|
5R01CA112552-08
|
$220,481
|
$110,241
|
FERGUSON, KATHRYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Analysis of STAG2 Inactivation and Aneuploidy in Human Cancer
|
1R01CA169345-01A1
|
$322,317
|
$80,579
|
WALDMAN, TODD
|
GEORGETOWN UNIVERSITY
|
|
Angiogenesis-targeting therapy for glioblastoma
|
2R01CA129371-06
|
$594,234
|
$594,234
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Annexin A2 as a Novel Enhancer of Tumor-Associated Antigen Processing
|
1F30CA167912-01A1
|
$42,232
|
$42,232
|
Andersen, Brian
|
UNIVERSITY OF MINNESOTA
|
|
Anticancer Agents from Plant- and Lichen-Associated Fungi of the Sonoran Desert
|
5R01CA090265-09
|
$242,834
|
$60,709
|
GUNATILAKA, LESLIE
|
UNIVERSITY OF ARIZONA
|
|
Anticancer Drug Pharmacology in Very Young Children
|
5R01CA154619-02
|
$407,467
|
$407,467
|
STEWART, CLINTON
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Apical-basal polarity signaling in glioblastoma
|
3R01CA149258-04S1
|
$65,622
|
$65,622
|
Ghosh, Sourav
|
UNIVERSITY OF ARIZONA
|
|
Apical-basal polarity signaling in glioblastoma
|
5R01CA149258-04
|
$291,837
|
$291,837
|
Ghosh, Sourav
|
UNIVERSITY OF ARIZONA
|
|
Apoptosis driven by elastase inhibitor: new approach to detection and study.
|
1R21CA178365-01
|
$191,944
|
$191,944
|
DIDENKO, VLADIMIR
|
BAYLOR COLLEGE OF MEDICINE
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S1
|
$75,000
|
$2,250
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-35
|
$3,676,771
|
$110,303
|
CRESS, ANNE
|
UNIVERSITY OF ARIZONA
|
|
Assaying GBM growth and therapy response in single cells and tumorspheres (PQ17)
|
5R01CA170592-02
|
$486,240
|
$486,240
|
LIGON, KEITH
|
DANA-FARBER CANCER INST
|
|
Astatine And Iodine Radiolabeled Monoclonal Antibodies
|
5R01CA042324-27
|
$440,288
|
$440,288
|
ZALUTSKY, MICHAEL
|
DUKE UNIVERSITY
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$36,212
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
ATP-Dependent Chromatin Remodeling in Human Malignancy
|
5R01CA163915-02
|
$307,421
|
$76,855
|
Crabtree, Gerald
|
STANFORD UNIVERSITY
|
|
Augmented Reality Head Mounted Display for Magnetic Resonance Imaging Guided Inte
|
2R44CA168271-02A1
|
$457,140
|
$457,140
|
Nevo, Erez
|
ROBIN MEDICAL, INC.
|
Total relevant funding to Brain for this search: $171,170,883
|